Skip to content

A full-service CRO Committed to research ethics excellence

achieve your goals with us
Discover our expertise

Our CRO Services

Discover all of the clinical research services offered by our Contract Research Organization.

Medical Writing

Study Management

Study Monitoring

Data Management

Biostatistics

Medical affairs

Phase I-III studies

Phase IIIB - IV studies

Discover our services

Our CRO Expertise

ethica CRO’s multidisciplinary management team has extensive scientific expertise and a depth of clinical management experience to manage your clinical development program. Our Contract Research Organization has extensive experience designing and conducting studies using various designs in dermatology, neurology, respiratory disorder, medical devices, Canadian research and investigator Initiated trials. Our expertise ensures that the design of the study and its resourcing are optimized to meet your clinical objectives within the predetermined budget.

Learn more

A CRO That Puts Quality First

Our commitment to you

At ethica CRO, the research participant lies at the heart of what we do. ethica CRO is the 1st accredited Contract Research Organization in the world and an industry leader in research ethics. We take pride in delivering superior client outcomes while ensuring the welfare, safety and rights of research participants. We rely on our human research protection program, quality management system, and innovative data technology to deliver highly responsive clinical research services according to the highest standards of ethical and scientific practice.

Learn more

Case Studies

Investigator-Initiated Trials

IIT
Our team at ethica CRO managed a series of investigator-initiated trials (IITs) for aUS-based pharmaceuticals company. The main objective of these trials was to demonstrate the efficacy of botulinum toxin (BTX) for a number of off-label indications for aesthetic applications, as BTX was only approved for the treatment of glabellar lines at the time. Another purpose of these IITs was to enhance understanding of the effects and impacts of this drug, such as patient satisfaction, diffusion, duration of action, and social perception, among other factors.
Read the case study

Ensuring Data Consistency within a Diverse CF Population

Respiratory Disease
Hundreds of millions of people around the world suffer from respiratory diseases—asthma, cystic fibrosis (CF), and bronchiectasis being among the most prevalent conditions. CF affects 1 in every 3600 children born in Canada, making it the most common fatal genetic disease in our country. There is currently no cure for CF, but there exist treatment options that have been shown to improve the symptoms and quality of life of people living with this debilitating condition.
Read the case study

Meeting Unique Technical Challenges: The Case of FDA’s First Approval of a Dermal Filler for the Treatment of Acne Scars

Dermatology
Acne is the most common skin disorder in the U.S. affecting 40-50 million people. Up to 95% of people with acne may go on to suffer from scarring. Acne scarring can have significant impact on well-being and quality of life, particularly for people with moderate to severe acne scarring.
Read the case study